Logo image of BLFY

BLUE FOUNDRY BANCORP (BLFY) Stock Fundamental Analysis

NASDAQ:BLFY - Nasdaq - US09549B1044 - Common Stock - Currency: USD

9.11  -0.09 (-0.98%)

After market: 9.11 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to BLFY. BLFY was compared to 396 industry peers in the Banks industry. Both the profitability and financial health of BLFY have multiple concerns. While showing a medium growth rate, BLFY is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

BLFY had negative earnings in the past year.
In the past year BLFY had a positive cash flow from operations.
BLFY had negative earnings in 4 of the past 5 years.
In multiple years BLFY reported negative operating cash flow during the last 5 years.
BLFY Yearly Net Income VS EBIT VS OCF VS FCFBLFY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

BLFY has a worse Return On Assets (-0.56%) than 94.95% of its industry peers.
The Return On Equity of BLFY (-3.60%) is worse than 93.69% of its industry peers.
Industry RankSector Rank
ROA -0.56%
ROE -3.6%
ROIC N/A
ROA(3y)-0.27%
ROA(5y)-0.87%
ROE(3y)-1.69%
ROE(5y)-5.77%
ROIC(3y)N/A
ROIC(5y)N/A
BLFY Yearly ROA, ROE, ROICBLFY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -5 -10 -15

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BLFY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BLFY Yearly Profit, Operating, Gross MarginsBLFY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

3

2. Health

2.1 Basic Checks

BLFY does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BLFY has been reduced compared to 1 year ago.
Compared to 5 years ago, BLFY has less shares outstanding
The debt/assets ratio for BLFY is higher compared to a year ago.
BLFY Yearly Shares OutstandingBLFY Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
BLFY Yearly Total Debt VS Total AssetsBLFY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

The Debt to FCF ratio of BLFY is 1.64, which is an excellent value as it means it would take BLFY, only 1.64 years of fcf income to pay off all of its debts.
BLFY has a Debt to FCF ratio (1.64) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.03 indicates that BLFY is not too dependend on debt financing.
BLFY's Debt to Equity ratio of 0.03 is amongst the best of the industry. BLFY outperforms 84.60% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 1.64
Altman-Z N/A
ROIC/WACCN/A
WACC11.14%
BLFY Yearly LT Debt VS Equity VS FCFBLFY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
BLFY Yearly Current Assets VS Current LiabilitesBLFY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

4

3. Growth

3.1 Past

BLFY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -40.00%.
The Revenue has decreased by -1.36% in the past year.
BLFY shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.88% yearly.
EPS 1Y (TTM)-40%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)-1.36%
Revenue growth 3Y-4.68%
Revenue growth 5Y-2.88%
Sales Q2Q%5.94%

3.2 Future

BLFY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.44% yearly.
Based on estimates for the next years, BLFY will show a very strong growth in Revenue. The Revenue will grow by 20.83% on average per year.
EPS Next Y15.12%
EPS Next 2Y32.44%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year21.46%
Revenue Next 2Y20.83%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BLFY Yearly Revenue VS EstimatesBLFY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M 50M
BLFY Yearly EPS VS EstimatesBLFY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 -0.2 -0.4 -0.6

1

4. Valuation

4.1 Price/Earnings Ratio

BLFY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BLFY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BLFY Price Earnings VS Forward Price EarningsBLFY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

81.06% of the companies in the same industry are cheaper than BLFY, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 33.35
EV/EBITDA N/A
BLFY Per share dataBLFY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

BLFY's earnings are expected to grow with 32.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.44%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

BLFY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BLUE FOUNDRY BANCORP

NASDAQ:BLFY (7/18/2025, 8:00:01 PM)

After market: 9.11 0 (0%)

9.11

-0.09 (-0.98%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)04-30 2025-04-30/bmo
Earnings (Next)07-30 2025-07-30/bmo
Inst Owners54.38%
Inst Owner Change0.29%
Ins Owners3.1%
Ins Owner Change-3.11%
Market Cap197.87M
Analysts45.71
Price Target10.07 (10.54%)
Short Float %2.62%
Short Ratio8.94
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.31%
Min EPS beat(2)25.03%
Max EPS beat(2)27.58%
EPS beat(4)3
Avg EPS beat(4)23.7%
Min EPS beat(4)-6.44%
Max EPS beat(4)48.65%
EPS beat(8)7
Avg EPS beat(8)27.98%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.95%
Min Revenue beat(2)-4.31%
Max Revenue beat(2)0.41%
Revenue beat(4)2
Avg Revenue beat(4)-2.39%
Min Revenue beat(4)-13%
Max Revenue beat(4)7.32%
Revenue beat(8)3
Avg Revenue beat(8)-2.95%
Revenue beat(12)5
Avg Revenue beat(12)-1.75%
Revenue beat(16)9
Avg Revenue beat(16)-0.25%
PT rev (1m)-2.47%
PT rev (3m)-5.95%
EPS NQ rev (1m)0%
EPS NQ rev (3m)12.86%
EPS NY rev (1m)0%
EPS NY rev (3m)10.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)7.17%
Revenue NY rev (1m)0%
Revenue NY rev (3m)5.72%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.87
P/FCF 33.35
P/OCF 32.31
P/B 0.61
P/tB 0.61
EV/EBITDA N/A
EPS(TTM)-0.56
EYN/A
EPS(NY)-0.14
Fwd EYN/A
FCF(TTM)0.27
FCFY3%
OCF(TTM)0.28
OCFY3.1%
SpS1.87
BVpS15.04
TBVpS15.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.56%
ROE -3.6%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 14.61%
ROA(3y)-0.27%
ROA(5y)-0.87%
ROE(3y)-1.69%
ROE(5y)-5.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 1.64
Debt/EBITDA N/A
Cap/Depr 6.23%
Cap/Sales 0.47%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score3
WACC11.14%
ROIC/WACCN/A
Cap/Depr(3y)133.37%
Cap/Depr(5y)257.23%
Cap/Sales(3y)7.64%
Cap/Sales(5y)13.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y15.12%
EPS Next 2Y32.44%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.36%
Revenue growth 3Y-4.68%
Revenue growth 5Y-2.88%
Sales Q2Q%5.94%
Revenue Next Year21.46%
Revenue Next 2Y20.83%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y177.35%
FCF growth 3YN/A
FCF growth 5Y8.79%
OCF growth 1Y582.28%
OCF growth 3YN/A
OCF growth 5Y-1.39%